Published by: Pharmex Middle East (Aland Institute)<\/p>\n
Region Covered: Middle East, North Africa, CIS, South Asia<\/p>\n
The Middle East pharmaceutical sector is entering a period of accelerated transformation driven by population growth, increasing healthcare expenditure, government localization programs, and rising demand for Active Pharmaceutical Ingredients (APIs), machinery, and advanced manufacturing technologies.<\/p>\n
Between 2024\u20132028, the pharmaceutical market in the Middle East is expected to grow at 8\u201312% CAGR, with Iran, Saudi Arabia, Egypt, the UAE, and Turkey forming the core of regional production and consumption.<\/p>\n
1. Middle East Pharmaceutical Market \u2013 Regional Overview<\/p>\n
Market Size<\/strong><\/p>\n Middle East pharma market value (2024): ~USD 42 billion Projected market size (2028): ~USD 60 billion<\/p>\n Key Drivers<\/strong><\/p>\n Population across region: ~410 million<\/p>\n Strong demand for chronic disease treatments<\/p>\n Expansion of insurance coverage and state healthcare<\/p>\n API shortages leading to localization programs<\/p>\n Increased regulatory convergence (Saudi FDA, Iran IFDA, UAE MOH)<\/p>\n Top Markets in Production Capacity<\/p>\n 1. Turkey \u2013 Finished dosage forms<\/p>\n 2. Iran \u2013 APIs, biosimilars, and raw materials<\/p>\n 3. Saudi Arabia \u2013 Localization programs (Vision 2030)<\/p>\n 4. Egypt \u2013 Large consumer market<\/p>\n 5. UAE \u2013 Regional logistics hub<\/p>\n 2. API & Pharmaceutical Raw Materials Outlook<\/p>\n Global Context<\/strong><\/p>\n The API market is dominated by:<\/p>\n India (32% global share)<\/p>\n China (28% global share) However, due to supply-chain disruptions (COVID, trade barriers, rising costs in India\/China), Middle Eastern governments are aggressively investing in API localization.<\/p>\n Regional API Demand<\/p>\n Total API demand in Middle East (2024): USD 6.2 billion<\/p>\n Expected by 2028: USD 8.7 billion Iran\u2019s Role<\/strong><\/p>\n Iran stands out as:<\/p>\n The largest producer of pharmaceutical APIs in the Middle East, with:<\/p>\n Over 70 API-producing companies<\/p>\n Export partners including India, Russia, Algeria, Iraq, Syria, Pakistan, Afghanestan<\/p>\n Strong competitive advantage in narcotic APIs and niche intermediates<\/p>\n 3. Pharmaceutical Machinery & Technology Trends<\/p>\n Machinery and technology adoption in the region is driven by:<\/p>\n Key Trends<\/strong><\/p>\n Automation & digital GMP systems<\/p>\n Cleanroom technologies<\/p>\n High-containment systems<\/p>\n Advanced granulation and continuous manufacturing<\/p>\n Sterile and oncology production technologies<\/p>\n Regional Market Size<\/strong><\/p>\n Pharma machinery market (Middle East): USD 2.1B India, China, Germany, Italy, and Japan are the major suppliers.<\/p>\n 4. Technology Transfer & Investment Opportunities<\/p>\n Areas of High Demand in the Region<\/p>\n Oncology APIs<\/p>\n High-potent drugs (HPAPI)<\/p>\n Peptides<\/p>\n Hormonal APIs<\/p>\n Sterile injectables<\/p>\n Packaging modernization (track & trace, smart packaging)<\/p>\n Why the Region Is Attractive for Partnerships<\/p>\n Growing regional market<\/p>\n Increasing regulatory harmonization<\/p>\n Lower production costs compared to EU<\/p>\n Strong government incentives (Saudi Arabia, Iran, UAE)<\/p>\n 5. Pharmex Middle East \u2013 The Specialized Hub of the Region<\/p>\n Why Pharmex Matters<\/strong><\/p>\n Pharmex Middle East is currently the only fully specialized API & machinery exhibition in the region, unlike broader healthcare expos in UAE, Turkey, and Saudi Arabia.<\/p>\n Core Focus of Pharmex<\/p>\n APIs & intermediates<\/p>\n Pharmaceutical machinery & production lines<\/p>\n Packaging solutions<\/p>\n Technology transfer<\/p>\n R&D & formulation technologies<\/p>\n Raw materials and excipients<\/p>\n Participation Statistics (2024\u20132025)<\/p>\n 530+ exhibitors<\/p>\n 20,000+ professional visitors from 20+ countries<\/p>\n Delegations from:<\/p>\n India<\/p>\n Russia<\/p>\n Uzbekistan<\/p>\n Algeria<\/p>\n China<\/p>\n Oman<\/p>\n Pakistan<\/p>\n Iraq<\/p>\n Afghanestan<\/p>\n Cuba<\/p>\n Turkey<\/p>\n Tajikestan<\/p>\n Several African markets and…<\/p>\n <\/p>\n International Recognition<\/strong><\/p>\n Listed by JETRO Japan as one of the recommended pharmaceutical exhibitions in the Middle East<\/p>\n Selected by Corporate Vision UK as: 6. Outlook for 2026\u20132030<\/p>\n Expected Regional Shifts<\/p>\n API localization will accelerate<\/p>\n Machinery imports from India & China will increase<\/p>\n Iran will play a central role in API & semi-finished materials<\/p>\n Demand for tech transfer will triple<\/p>\n Pharma clusters in UAE & Saudi will rely on API suppliers from Iran, India, Turkey<\/p>\n Role of Pharmex 2026<\/p>\n Become the main meeting point of the Middle Eastern supply chain<\/p>\n Attract 650+ companies and 25+ international delegations<\/p>\n Serve as the strategic bridge between Asia and the Middle East pharma industry<\/p>\n Sources & References<\/strong><\/p>\n To ensure credibility, all data points cited are from publicly available international sources:<\/p>\n Global \/ Industrial<\/p>\n IQVIA Middle East Market Outlook 2024<\/p>\n UNIDO API Manufacturing Report 2023<\/p>\n WHO Pharmaceutical Systems Strengthening Reports<\/p>\n Trade Map \u2013 ITC (International Trade Centre)<\/p>\n Global Pharma Machinery Outlook 2024<\/p>\n Regional<\/p>\n PharmaBoardroom: Middle East 2024<\/p>\n Frost & Sullivan MENA Healthcare Valuation 2023<\/p>\n Gulf Health Council Regulatory Updates<\/p>\n Turkey Pharma Export Report 2024<\/p>\n Event-Related<\/p>\n JETRO (Japan External Trade Organization) \u2013 Trade Fair Listings<\/p>\n Corporate Vision UK \u2013 Global Business Awards 2025<\/p>\n Pharmex Middle East Official Post-Show Reports<\/p>\n","protected":false},"excerpt":{"rendered":" Published by: Pharmex Middle East (Aland Institute) Region Covered: Middle East, North Africa, CIS, South Asia The Middle East pharmaceutical sector is entering a period of accelerated transformation driven by population growth, increasing healthcare expenditure, government localization programs, and rising demand for Active Pharmaceutical Ingredients (APIs), machinery, and advanced manufacturing technologies. Between 2024\u20132028, the pharmaceutical […]<\/p>\n","protected":false},"author":27,"featured_media":8464,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8463","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmex-news"],"yoast_head":"\n
\nSource: IQVIA Middle East Market Report 2024<\/p>\n
\nSource: UNIDO API Industrial Assessment 2023<\/p>\n
\nSource: PharmaBoardroom MENA Market Insights 2024<\/p>\n
\nSource: Global Process Equipment Outlook 2024<\/p>\n
\n\u201cMost Influential Pharmaceutical Industry Event \u2013 Middle East (2025)\u201d<\/p>\n